Our RD-Activities
CCP: First RD in the program
To initiate the program, CCP has established research and development projects on the following rare diseases:
- Netherton syndrome
- Angelman syndrome
- Prader-Willi syndrome
- SPATA5 syndrome
- Diamond-Blackfan anemia
- Autosomal recessive congenital ichthyosis
Preclinical therapeutics development in CCP – objectives
- GLP study
- to provide fully supported access to preclinical development accordance to legal regulators
CCP obtained and good laboratory praxis (GLP) certificate that improves our possibilities of preclinical testing of therapies:
